நிறுவனம் க்கு ப்ரோடீந் கண்டுபிடிப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நிறுவனம் க்கு ப்ரோடீந் கண்டுபிடிப்பு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நிறுவனம் க்கு ப்ரோடீந் கண்டுபிடிப்பு Today - Breaking & Trending Today

Ycharos announces publication of first characterization data and formation of industry advisory committee

Ycharos announces publication of first characterization data and formation of industry advisory committee
news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.

Peter Mcpherson , Emily Henderson , Ycharos Inc , Industry Advisory Committee , Horizon Discoverya Perkinelmer Company , Institute For Protein Innovation , Neuro Montreal Neurological Institute , Montreal Neurological Institute Hospital , Distinguished James Mcgill , Horizon Discovery , Perkinelmer Company , Protein Innovation , Thermo Fisher , Antibody Registry , பீட்டர் மக்ஃபர்ஸந் , எமிலி ஹென்டர்சன் , நிறுவனம் க்கு ப்ரோடீந் கண்டுபிடிப்பு , நரம்பியல் மான்ட்ரியல் நரம்பியல் நிறுவனம் , மான்ட்ரியல் நரம்பியல் நிறுவனம் மருத்துவமனை , அடிவானம் கண்டுபிடிப்பு , ப்ரோடீந் கண்டுபிடிப்பு , தெர்மோ மீனவர் , ஆன்டிபாடி பதிவு ,

BioMarin Appoints Former Goldman Sachs Partner and Life Sciences Executive, Maykin Ho, Ph.D. to Board of Directors

Share this article
Share this article
SAN RAFAEL, Calif., Feb. 18, 2021 /PRNewswire/ BioMarin Pharmaceutical Inc. (Nasdaq:BMRN), a global leader in providing therapies for rare genetic diseases, today announced the appointment of former Goldman Sachs partner and executive in the life sciences industry, Maykin Ho, Ph.D., to its Board of Directors.
We are thrilled to welcome Maykin to BioMarin s Board of Directors. She brings a breadth and depth of experience in the healthcare industry and finance to an already exceptional board, said Jean-Jacques Bienaimé, Chairman and Chief Executive Officer at BioMarin. Maykin brings an important perspective to support BioMarin s growth trajectory as we strive to address the unmet medical needs of people affected by rare genetic diseases and deliver scientific breakthroughs. ....

New York , United States , Hong Kong , Goldman Sachs , Debra Charlesworth , Traci Mccarty , Jean Jacques Bienaim , Fuqua School Of Business , Management Program , Grail Inc , Dupont De Nemours Company , Downstate Medical Center , Biomarin Pharmaceutical Inc , University Of New York , Goldman Sachs Group , Fibrogen Inc , Harvard Medical School , Research Center , Dupont Merck Pharmaceuticals , Agios Pharmaceuticals Inc , Duke University , Institute For Protein Innovation , Biomarin Pharmaceutical , Chief Executive Officer , Aaron Diamond , Qiming Venture Partners ,